A summary of the new GINA strategy: a roadmap to asthma control
View/ Open
Author
Reddel, Helen K.
Bateman, Eric D.
Becker, Allan
Boulet, Louis-Philippe
Cruz, Alvaro A.
Haahtela, Tari
Hurd, Suzanne S.
Inoue, Hiromasa
de Jongste, Johan C.
Lemanske, Robert F.
Levy, Mark L.
O'Byrne, Paul M.
Paggiaro, Pierluigi
Pedersen, Soren E.
Pizzichini, Emilio
Soto-Quiroz, Manuel
Szefler, Stanley J.
Wong, Gary W.K.
FitzGerald, J. Mark
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1183/13993003.00853-2015Metadata
Show full item recordCitation
Reddel, H. K., E. D. Bateman, A. Becker, L. Boulet, A. A. Cruz, J. M. Drazen, T. Haahtela, et al. 2015. “A summary of the new GINA strategy: a roadmap to asthma control.” The European Respiratory Journal 46 (3): 622-639. doi:10.1183/13993003.00853-2015. http://dx.doi.org/10.1183/13993003.00853-2015.Abstract
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA report was published in 2014, and updated in 2015, reflecting an evolving understanding of heterogeneous airways disease, a broader evidence base, increasing interest in targeted treatment, and evidence about effective implementation approaches. During development of the report, the clinical utility of recommendations and strategies for their practical implementation were considered in parallel with the scientific evidence. This article provides a summary of key changes in the GINA report, and their rationale. The changes include a revised asthma definition; tools for assessing symptom control and risk factors for adverse outcomes; expanded indications for inhaled corticosteroid therapy; a framework for targeted treatment based on phenotype, modifiable risk factors, patient preference, and practical issues; optimisation of medication effectiveness by addressing inhaler technique and adherence; revised recommendations about written asthma action plans; diagnosis and initial treatment of the asthma−chronic obstructive pulmonary disease overlap syndrome; diagnosis in wheezing pre-school children; and updated strategies for adaptation and implementation of GINA recommendations.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554554/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:22856882
Collections
- HMS Scholarly Articles [17917]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)